Select language:  
1800 620 420
Close menu

Author: Michael Yare

Latest ALLG clinical trial recruiting for CML

Information on the latest clinical trial.

  • Chronic myeloid leukaemia
  • Clinical trials
Read more
Molecule

Living with blood cancer and pets

Read our top tips on how to safely care for your pets while undergoing and recovering from treatment.

  • Lifestyle and living well
Read more
Lyndell Wills with her dog Meggs

The importance of molecular response in CML

Dr Susan Branford's research involved assessing people with CML to determine if monitoring the level of disease during therapy using a molecular marker could predict treatment outcome.

  • Chronic myeloid leukaemia
  • Research
Read more
Professor Susan Branford

Second drug treatment now controlling Leanne’s CML

Leanne Pitman knew she wasn’t well, but it took seven months before she was finally diagnosed with chronic myeloid leukaemia (CML).

  • Chronic myeloid leukaemia
Read more
Leanne Pitman at the Penola café

Latest ALLG clinical trials recruiting for AML

Four clinical trials run by the Australasian Leukaemia & Lymphoma Group* (ALLG) are currently open to a range of people with acute myeloid leukaemia (AML) across Australia.

  • Acute myeloid leukaemia
  • Clinical trials
  • Research
Read more
Professor Paula Marlton

New 3D models could revolutionise drug testing

Dr Laura bray hopes her work will provide answers to the many unknowns faced by people with AML.

  • Acute myeloid leukaemia
Read more
Dr Laura Bray in the lab 2

Why Dr Morrison pays attention to his vitamin C intake

Internationally recognised leader in stem cell research, Dr Sean Morrison, makes sure he gets his daily requirement of vitamin C – not a lot more and definitely no less!

  • Acute myeloid leukaemia
  • Research
Read more
Dr Sean Morrison

Dr Traver’s fascination with how leukaemia happens

Dr David Traver is an experimental haematologist who specialises in haematopoiesis.

  • Acute myeloid leukaemia
  • Research
Read more
Dr David Traver

Expert Series: AProf. Daniel Thomas on mutation-specific targeted therapies for AML – “a new era of medicine has begun”

Dr Daniel Thomas brought us up-to-speed on his multi-faceted work in the field of myeloid leukaemia.

  • Acute myeloid leukaemia
  • Interviews with experts
  • Research
Read more
A/Prof Dan Thomas

The ups and downs of leukaemia… ‘one day at a time’

Geoff shares his story of his shock diagnosis with acute monocytic myeloid leukaemia - a sub-type of AML.

  • Acute myeloid leukaemia
Read more
Geoffrey Hamilton with his family in hospital